285 related articles for article (PubMed ID: 29799009)
1. Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients.
Wang C; Yin R; Dai J; Gu Y; Cui S; Ma H; Zhang Z; Huang J; Qin N; Jiang T; Geng L; Zhu M; Pu Z; Du F; Wang Y; Yang J; Chen L; Wang Q; Jiang Y; Dong L; Yao Y; Jin G; Hu Z; Jiang L; Xu L; Shen H
Nat Commun; 2018 May; 9(1):2054. PubMed ID: 29799009
[TBL] [Abstract][Full Text] [Related]
2. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients.
Wang R; Zhang Y; Pan Y; Li Y; Hu H; Cai D; Li H; Ye T; Luo X; Zhang Y; Li B; Shen L; Sun Y; Chen H
Oncotarget; 2015 Oct; 6(33):34300-8. PubMed ID: 26486077
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients.
Zhang XC; Wang J; Shao GG; Wang Q; Qu X; Wang B; Moy C; Fan Y; Albertyn Z; Huang X; Zhang J; Qiu Y; Platero S; Lorenzi MV; Zudaire E; Yang J; Cheng Y; Xu L; Wu YL
Nat Commun; 2019 Apr; 10(1):1772. PubMed ID: 30992440
[TBL] [Abstract][Full Text] [Related]
5. Epidermal Growth Factor Receptor Mutations in Resectable Non-Small Cell Lung Cancer Patients and their Potential Role in the Immune Landscape.
Xia W; Mao W; Chen R; Lu R; Liu F; He Y; Wang S; Li X; Zheng M
Med Sci Monit; 2019 Nov; 25():8764-8776. PubMed ID: 31746315
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and sequence complexity of anaplastic lymphoma kinase gene fusions in Chinese lung cancer patients.
Tian HX; Zhang XC; Yang JJ; Guo WB; Chen ZH; Wang Z; Wu YL
Lung Cancer; 2017 Dec; 114():90-95. PubMed ID: 29173772
[TBL] [Abstract][Full Text] [Related]
7. Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy.
Sun S; Du W; Sun Q; Zhao X; Qin B; Shi D; Wan C; Wu Z
Cancer Med; 2021 Oct; 10(20):7360-7372. PubMed ID: 34599863
[TBL] [Abstract][Full Text] [Related]
8. Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.
Jin R; Liu C; Zheng S; Wang X; Feng X; Li H; Sun N; He J
Cancer Biol Med; 2020 Aug; 17(3):768-781. PubMed ID: 32944405
[No Abstract] [Full Text] [Related]
9. Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer.
Li Y; Li Y; Yang T; Wei S; Wang J; Wang M; Wang Y; Zhou Q; Liu H; Chen J
PLoS One; 2013; 8(1):e52093. PubMed ID: 23341890
[TBL] [Abstract][Full Text] [Related]
10. The genomic landscape of nonsmall cell lung carcinoma in never smokers.
Boeckx B; Shahi RB; Smeets D; De Brakeleer S; Decoster L; Van Brussel T; Galdermans D; Vercauter P; Decoster L; Alexander P; Berchem G; Ocak S; Vuylsteke P; Deschepper K; Lambrechts M; Cappoen N; Teugels E; Lambrechts D; De Greve J
Int J Cancer; 2020 Jun; 146(11):3207-3218. PubMed ID: 31745979
[TBL] [Abstract][Full Text] [Related]
11. EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer.
Wang Z; Zhang X; Bai H; Zhao J; Zhuo M; An T; Duan J; Yang L; Wu M; Wang S; Wang Y; Wu Y; Wang J
Oncology; 2012; 83(5):248-56. PubMed ID: 22964709
[TBL] [Abstract][Full Text] [Related]
12. Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis.
Wang S; Ma P; Ma G; Lv Z; Wu F; Guo M; Li Y; Tan Q; Song S; Zhou E; Geng W; Duan Y; Li Y; Jin Y
Eur J Cancer; 2020 Jan; 124():1-14. PubMed ID: 31707279
[TBL] [Abstract][Full Text] [Related]
13. Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment.
Haratani K; Hayashi H; Tanaka T; Kaneda H; Togashi Y; Sakai K; Hayashi K; Tomida S; Chiba Y; Yonesaka K; Nonagase Y; Takahama T; Tanizaki J; Tanaka K; Yoshida T; Tanimura K; Takeda M; Yoshioka H; Ishida T; Mitsudomi T; Nishio K; Nakagawa K
Ann Oncol; 2017 Jul; 28(7):1532-1539. PubMed ID: 28407039
[TBL] [Abstract][Full Text] [Related]
14. Mutation Spectrum of
Mao L; Zhao W; Li X; Zhang S; Zhou C; Zhou D; Ou X; Xu Y; Tang Y; Ou X; Hu C; Ding X; Luo P; Yu S
Pathol Oncol Res; 2021; 27():602726. PubMed ID: 34257561
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China.
Zhou Y; Yang Y; Yang C; Chen Y; Yang C; Du Y; Zhao G; Guo Y; Ye L; Huang Y
Oncotarget; 2017 Feb; 8(9):15023-15033. PubMed ID: 28107191
[TBL] [Abstract][Full Text] [Related]
16. EGFR mutation status and its impact on survival of Chinese non-small cell lung cancer patients with brain metastases.
Luo D; Ye X; Hu Z; Peng K; Song Y; Yin X; Zhu G; Ji Q; Peng Y
Tumour Biol; 2014 Mar; 35(3):2437-44. PubMed ID: 24197981
[TBL] [Abstract][Full Text] [Related]
17. [Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].
Pan ZK; Zhang L; Zhang X; Wang X; Li N; Xu F; Chang JH; Guan ZZ
Ai Zheng; 2005 Aug; 24(8):919-23. PubMed ID: 16086866
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.
Liu SY; Dong ZY; Wu SP; Xie Z; Yan LX; Li YF; Yan HH; Su J; Yang JJ; Zhou Q; Zhong WZ; Tu HY; Yang XN; Zhang XC; Wu YL
Lung Cancer; 2018 Nov; 125():86-92. PubMed ID: 30429043
[TBL] [Abstract][Full Text] [Related]
19. EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer.
Wu M; Zhao J; Song SW; Zhuo M; Wang X; Bai H; Wang S; Yang L; An T; Zhang Y; Duan J; Wang Y; Guo Q; Liu X; Liu N; Wang J
Lung Cancer; 2010 Mar; 67(3):343-7. PubMed ID: 19477549
[TBL] [Abstract][Full Text] [Related]
20. Detection and clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with advanced non-small cell lung cancer.
Bai H; Wang Z; Wang Y; Zhuo M; Zhou Q; Duan J; Yang L; Wu M; An T; Zhao J; Wang J
PLoS One; 2013; 8(2):e54170. PubMed ID: 23418425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
